SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-010211
Filing Date
2021-02-01
Accepted
2021-02-01 16:32:37
Documents
1
Group Members
MERCK B.V.MERCK VENTURES B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm214647d2_sc13g.htm SC 13G 89683
  Complete submission text file 0001104659-21-010211.txt   91354
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89626 | Film No.: 21577105
SIC: 2834 Pharmaceutical Preparations

Mailing Address FRANKFURTER STR. 250 DARMSTADT 2M 64293
Business Address FRANKFURTER STR. 250 DARMSTADT 2M 64293 004961517245950
Merck KGaA (Filed by) CIK: 0001764133 (see all company filings)

IRS No.: 980233737 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G